Literature DB >> 18180901

Effects of systemic antibiotic therapy on bacterial persistence in the respiratory tract of mechanically ventilated patients.

Stefan Visscher1, Carolina A M Schurink, Wilhelmina G Melsen, Peter J F Lucas, Marc J M Bonten.   

Abstract

OBJECTIVE: Bacterial respiratory tract colonization predisposes critically ill patients to intensive care unit (ICU)-acquired infections. It is unclear to what extent systemic antibiotics affect colonization persistence. Persistence of respiratory tract colonization, and the effects of systemic antibiotics hereon, were determined in a cohort of ICU patients.
DESIGN: Clinical and microbiological data were collected from 715 admitted mechanically ventilated ICU patients with bacterial growth documented in respiratory tract samples. First day of colonization, persistence of colonization and antibiotic effects hereon were analyzed for six groups of pathogens: Pseudomonas aeruginosa, Acinetobacter species, Enterobacteriaceae, Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae. Systemic antibiotics were grouped into 'effective' and 'ineffective' antibiotics, based on in-vitro susceptibility data for the relevant bacteria. The effects of antibiotics were quantified as relative risk (RR) of bacterial persistence in the absence of effective antibiotics. MEASUREMENTS AND
RESULTS: Persistence of colonization differed significantly between pathogens, ranging from 4 days (median) for H. influenzae and Strep. pneumoniae to 8 days for P. aeruginosa. Systemic antibiotics were administered on 7,102 (61%) of patient days. Antibiotic use was associated with non-persistence for all pathogens, except Acinetobacter species and P. aeruginosa. RR for non-persistence (as compared to ineffective or no antibiotics) ranged from 3.1 (95% CI 1.4-6.6) for H. influenzae to 0.5 (0.3-1.0) for Acinetobacter species.
CONCLUSIONS: In mechanically ventilated patients, persistence dynamics of bacterial respiratory tract colonization, and the effects of (in-vitro) effective antibiotics hereon, are pathogen-specific.

Entities:  

Mesh:

Year:  2008        PMID: 18180901     DOI: 10.1007/s00134-007-0984-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  11 in total

Review 1.  Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Authors:  Thomas S Murray; Marie Egan; Barbara I Kazmierczak
Journal:  Curr Opin Pediatr       Date:  2007-02       Impact factor: 2.856

2.  Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia.

Authors:  S Ewig; A Torres; M El-Ebiary; N Fábregas; C Hernández; J González; J M Nicolás; L Soto
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients.

Authors:  M J Bonten; D C Bergmans; A W Ambergen; P W de Leeuw; S van der Geest; E E Stobberingh; C A Gaillard
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

4.  Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients.

Authors:  D C Bergmans; M J Bonten; P W De Leeuw; E E Stobberingh
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Indications for antibiotic use in ICU patients: a one-year prospective surveillance.

Authors:  D C Bergmans; M J Bonten; C A Gaillard; F H van Tiel; S van der Geest; P W de Leeuw; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1997-04       Impact factor: 5.790

6.  Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.

Authors:  J M Sirvent; A Torres; M El-Ebiary; P Castro; J de Batlle; A Bonet
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

7.  Bacterial persistence: a model of survival in changing environments.

Authors:  Edo Kussell; Roy Kishony; Nathalie Q Balaban; Stanislas Leibler
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

8.  Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia.

Authors:  K M C Verhamme; W De Coster; L De Roo; H De Beenhouwer; G Nollet; J Verbeke; I Demeyer; P Jordens
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-28       Impact factor: 3.254

9.  A Bayesian decision-support system for diagnosing ventilator-associated pneumonia.

Authors:  Carolina A M Schurink; Stefan Visscher; Peter J F Lucas; Henk J van Leeuwen; Erik Buskens; Reinier G Hoff; Andy I M Hoepelman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

10.  Persister cells and tolerance to antimicrobials.

Authors:  Iris Keren; Niilo Kaldalu; Amy Spoering; Yipeng Wang; Kim Lewis
Journal:  FEMS Microbiol Lett       Date:  2004-01-15       Impact factor: 2.742

View more
  8 in total

1.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

Review 2.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

3.  Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa.

Authors:  Fabio Ferrari; Qin Lu; Cassio Girardi; Olivier Petitjean; Charles-Hugo Marquette; Frederic Wallet; Jean-Jacques Rouby
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

4.  Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept.

Authors:  Sara Gil-Perotin; Paula Ramirez; Veronica Marti; Jose Miguel Sahuquillo; Eva Gonzalez; Isabel Calleja; Rosario Menendez; Juan Bonastre
Journal:  Crit Care       Date:  2012-05-23       Impact factor: 9.097

5.  Biofilm formation on three different endotracheal tubes: a prospective clinical trial.

Authors:  Hulda R Thorarinsdottir; Thomas Kander; Anna Holmberg; Sarunas Petronis; Bengt Klarin
Journal:  Crit Care       Date:  2020-06-29       Impact factor: 9.097

Review 6.  Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Authors:  Richard Pugh; Chris Grant; Richard P D Cooke; Ged Dempsey
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24

7.  Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study.

Authors:  Neha M Doshi; Charles H Cook; Kari L Mount; Stanislaw P Stawicki; Erin N Frazee; Heather A Personett; Garrett E Schramm; Heather M Arnold; Claire V Murphy
Journal:  BMC Anesthesiol       Date:  2013-11-25       Impact factor: 2.217

Review 8.  Year in review in Intensive Care Medicine, 2008: I. Brain injury and neurology, renal failure and endocrinology, metabolism and nutrition, sepsis, infections and pneumonia.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-12-09       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.